Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zeteo Tech develops and commercializes fieldable biological time-of-flight mass spectrometers, branded as digitalMALDI, that provide fully automated, near real-time identification of airborne microbes, proteins, lipids and bio-threat agents from aerosols and human breath for infectious disease screening (including tuberculosis) and biodefense applications; the technology is being deployed and validated through U.S. Department of Homeland Security, Department of Defense, NIH/NIAID and Bill & Melinda Gates Foundation–funded programs, as well as through licensing to BioFlyte for environmental bioaerosol surveillance.[4][5][7][9][11]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zeteo Tech.